Double-blind controlled trial of amylopectin sulphate (Depepsen) in the symptomatic treatment of duodenal ulcer.
Authors:
- J H BaronJBJ H Baron
- R J GribbleRGR J Gribble
- D J HoldstockDHD J Holdstock
- J J MisiewiczJMJ J Misiewicz
Abstract
In a double-blind controlled trial amylopectin sulphate (Depepsen) had no significant advantage over placebo in the symptomatic treatment of duodenal ulcer.Keywords
This publication has 6 references indexed in Scilit:
- A controlled trial of antacid, propantheline and amylopectin sulfate in duodenal ulcer.1973
- A Trial of Amylopectin Sulfate (SN-263) and Propantheline Bromide in the Long Term Treatment of Chronic Duodenal UlcerGastroenterology, 1972
- A Controlled Study on the Use of Propantheline and Amylopectin Sulfate (SN-263) for Recurrences in Duodenal UlcerGastroenterology, 1970
- Specific Inhibition of Gastric Pepsin in the Treatment of Gastric UlcerGastroenterology, 1969
- EFFECT OF A SYNTHETIC SULFATED POLYSACCHARIDE (SN‐263)* ON GASTRIC PEPTIC ACTIVITY IN HUMANSAnnals of the New York Academy of Sciences, 1967
- EFFECT OF DEPEPSEN IN THE TREATMENT OF PEPTIC ULCERAnnals of the New York Academy of Sciences, 1967